Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Equity Income (2016 - 2024)

Bristol Myers Squibb (BMYMP) has disclosed Equity Income for 15 consecutive years, with -$23.0 million as the latest value for Q3 2024.

  • Quarterly Equity Income fell 227.78% to -$23.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Sep 2024, down 84.42% year-over-year, with the annual reading at -$4.0 million for FY2019, 104.3% down from the prior year.
  • Equity Income for Q3 2024 was -$23.0 million at Bristol Myers Squibb, down from $28.0 million in the prior quarter.
  • The five-year high for Equity Income was $40.0 million in Q3 2021, with the low at -$23.0 million in Q3 2024.
  • Average Equity Income over 4 years is $13.7 million, with a median of $23.0 million recorded in 2023.
  • Peak annual rise in Equity Income hit 354.55% in 2024, while the deepest fall reached 227.78% in 2024.
  • Over 4 years, Equity Income stood at $30.0 million in 2020, then surged by 33.33% to $40.0 million in 2021, then crashed by 55.0% to $18.0 million in 2023, then crashed by 227.78% to -$23.0 million in 2024.
  • According to Business Quant data, Equity Income over the past three periods came in at -$23.0 million, $28.0 million, and $18.0 million for Q3 2024, Q2 2024, and Q3 2023 respectively.